Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling
PTP1B and TC-PTP are highly related protein-tyrosine phosphatases (PTPs) that regulate the JAK/STAT signaling cascade essential for cytokine-receptor activation in immune cells. Here, we describe a novel immunotherapy approach whereby monocyte-derived dendritic cell (moDC) function is enhanced by mo...
Main Authors: | Claudia Penafuerte, Matthew Feldhammer, John R. Mills, Valerie Vinette, Kelly A. Pike, Anita Hall, Eva Migon, Gerard Karsenty, Jerry Pelletier, George Zogopoulos, Michel L. Tremblay |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-06-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1321185 |
Similar Items
-
Vanadium Compounds as PTP Inhibitors
by: Elsa Irving, et al.
Published: (2017-12-01) -
The secreted tyrosine phosphatase PtpA promotes Staphylococcus aureus survival in RAW 264.7 macrophages through decrease of the SUMOylation host response
by: Nadhuma Youssouf, et al.
Published: (2023-12-01) -
Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP
by: Luis Alberto Perez-Quintero, et al.
Published: (2024-04-01) -
The importance of including the C-terminal domain of PTP1B1-400 to identify potential antidiabetic inhibitors
by: Andrea Coronell-Tovar, et al.
Published: (2023-12-01) -
Dithiocarbamates as potential PTP1B inhibitors for diabetes management
by: Tanvi A. Deshpande, et al.
Published: (2022-01-01)